Steroid and Protein Regulators of Glial Cell Proliferation

  • Luis Goya
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 429)

Abstract

Normal development, differentiation and proliferation of tissues and cell types within multicellular organisms are stringently regulated by a complex combination of environmental factors that include systemic steroid and protein hormones, local and systemic acting growth factors, extracellular matrix components and cell-cell interactions. In most tissues, cell differentiation is accompanied by an arrest of proliferation and the maintenance of the growth arrested state is controled by specific hormonal signals which inhibit the expression or activity of growth stimulatory factors and/or induce growth suppressor gene products (Aaronson, 1991). However, for certain physiological processes, cell proliferation is neccessary to maintain populations of specific cell types. For instance, stem cells in the bone marrow provide a continuous source of hematopoietic cells in animals (Zipori, 1992). Quiescent cells will proliferate during tissue regeneration in a damaged organ, such in the liver (Fausto and Weber, 1993), whereas mammary epithelial cells are hormonally stimulated to proliferate during pregnancy and lactation (Ceriani, 1974). Finally, glial proliferation in response to brain neuronal damage has been well documented (Landis, 1994). The maintenance of these cells in the proliferative state, or the triggering of quiescent cells to proliferate, requires the selective stimulation of growth stimulatory gene products and/or suppression of growth inhibitory gene products.

Keywords

Glial Cell Glutamine Synthetase Early Passage Glutamine Synthetase Activity Glial Cell Proliferation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson S.A. 1991. Growth factors and cancer, Science 254: 1146.PubMedCrossRefGoogle Scholar
  2. Alexander D.B., Goya L., Webster M.K., Haraguchi T. and Firestone G.L. 1993. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells, Cancer Research 53: 1816.PubMedGoogle Scholar
  3. Barres B.A., Raff M.C., Gaese F., Bartke I., Dechant G. and Barde Y.-A. 1994. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367: 371–375.PubMedCrossRefGoogle Scholar
  4. Bazan J.F. 1989. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain, Biochem. Biophys. Res. Commun. 164: 788.CrossRefGoogle Scholar
  5. Berns E.M., Schuurmans A.L., Bolt J., Lamb D.J., Foekens J.A. and Mulder E. 1990. Antiproliferative effects of suramin on androgen responsive tumour cells, Fur. J. Cancer 26: 470.Google Scholar
  6. Brodie C. and Vemadakis A. 1991. Muscle-derived factors induce proliferation and astrocytic phenotypic expression in C6 glial cells. Glia 4: 269.PubMedCrossRefGoogle Scholar
  7. Carpenter G. 1992. Receptor tyrosine kinase substrates: src homology domains and signal transduction, FASEB J. 6: 3283.PubMedGoogle Scholar
  8. Ceriani R.C. 1974. Proceedings: hormones and other factors controlling growth in the mammary gland: a review, J. Invest. Derm. 63: 93.PubMedCrossRefGoogle Scholar
  9. Fausto N. and Weber E.M. 1993. Mechanisms of growth regulation in liver regeneration and hepatic carcinogenesis, Progress in liver diseases 11: 115.PubMedGoogle Scholar
  10. Firestone G.L., Maiyar A.C. and Ramos R.A. 1995. Steroid and protein regulators of normal and abnormal cell proliferation, in Hormones and Aging, Eds. P.S. Timiras, W.D. Quay and A. Vemadakis, pp. 325–359.Google Scholar
  11. Fridovich K.J., Hansen L.J., Keyomarsi K. and Pardee A.B. 1990. Progression through the cell cycle: an overview, Am. Rev. Resp. Dis. S3.Google Scholar
  12. Goya L., Alexander D.B., Webster M.K., Kern F.G., Guzman R.C., Nandi S. and Firestone G.L. 1993a. Overexpression of transforming growth factor alpha overrides the glucocorticoid-mediated suppression of Con8 mammary tumor cell growth in vitro and in vivo, Cancer Res. 53: 1816.PubMedGoogle Scholar
  13. Goya L., Maiyar A.C., Ge Y. and Firestone G.L. 1993b. Glucocorticoids induce a GI/GO cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha, Mol. Endocrinol. 7: 1121.Google Scholar
  14. Goya L., Rivero F. and Pascual-Leone A.M. 1995. Stress, glucocorticoids and aging, in Hormones and Aging, Eds. P.S. Timiras, W.D. Quay and A. Vernadakis, pp. 249–264.Google Scholar
  15. Goya L., Feng P-T., Aliabadi S. and Timiras P.S. 1996. Effect of growth factors on the in vitro growth and differentiation of early and late C6 glioma cells, Int. J. Devl. Neuroscience 14: 409–417.Google Scholar
  16. Haraguchi T., Alexander D.B., King D.S., Edwards C.P. and Firestone G.L. 1991. Identification of the glucocorticoìd suppressible mitogen from rat hepatoma cells as an angiogenic platelet-derived growth factor A-chain homodimer, J. Biol. Chem. 266: 18299.Google Scholar
  17. Hung W.C., Chuang L.Y., Tsai J.H. and Chang C.C. 1993. Effects of insulin on TGF-beta I-induced cell growth inhibition in the human hepatoma cell lines, Biochem. Mol. Biol. Int. 30: 655.Google Scholar
  18. Hunter T. and Karin M. 1992. The regulation of transcription by phosphorylation, Cell 70: 375.PubMedCrossRefGoogle Scholar
  19. Kiess W., Lee L., Graham D.E., Greenstein L., Tseng L.Y., Richler M.M. and Nissely S.P. 1989. Rat C6 glial cells synthesize insulin-like growth factor (1GF-I) and express IGF-1 receptors and IGF-II/mannose 6-phosphate receptors. Endocrinology 124: 1727.PubMedCrossRefGoogle Scholar
  20. Koch C.A., Anderson D., Moran M.F., Ellis C. and Pawson T. 1991. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins, Science 252: 668.PubMedCrossRefGoogle Scholar
  21. Landis D.M.D. 1994. The early reactions of non-neuronal cells to brain injury. Annu. Rev. Neurosci. 17: 133–51.PubMedCrossRefGoogle Scholar
  22. Lee K., Kentroti S. and Vernadakis A. 1992. Comparative biochemical, morphological and immunocytochemical studies between C6 glial cells of early and late passages and advanced passages of glial cells derived from aged mouse cerebral hemispheres. Glia 6: 245–257.PubMedCrossRefGoogle Scholar
  23. Lowe W.L., Meyer T., Karpen C.W. and Lorentzen L.R. 1992. Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor. Endocrinology 130: 2683.PubMedCrossRefGoogle Scholar
  24. Martinez-Hernandez A., Bell K.P. and Norenberg M.D. 1977. Glutamine synthetase-glial localization in the brain. Science 195: 1356.PubMedCrossRefGoogle Scholar
  25. Massague J. 1992. Receptors for the TGF-beta family, Cell 69: 1067.PubMedCrossRefGoogle Scholar
  26. Morrison R.S. and De Vellis J. 1981. Growth of purified astrocytes in chemically defined medium, Proc. Natl. Acad. Sci. USA 78: 7205.PubMedCrossRefGoogle Scholar
  27. Noble M., Murray K., Stroobant P., Waterfield M.D. and Riddle P. 1988. Platelet-derived growth factor promoted division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell, Nature 333: 556.CrossRefGoogle Scholar
  28. Pardee A.B. 1989. G1 events and regulation of cell proliferation, Science 246: 603.PubMedCrossRefGoogle Scholar
  29. Parker K.K., Norenberg M.D. and Vernadakis A. 1980. Transdifferentiation of C6 glial cells in culture, Science 208: 179.PubMedCrossRefGoogle Scholar
  30. Pines J. 1993. Arresting developments in cell-cycle control, Trends Biochem. Sci. 19: 143.Google Scholar
  31. Poduslo S.E. 1975. The isolation and characterization of a plasma membrane and myelin fraction derived from oligodendroglia of calf brain, J. Neurochem. 24: 647.PubMedGoogle Scholar
  32. Pruss R.M., Bartlett P.F., Gavridovic J., Lisak R.P. and Rattray S. 1982. Mitogens for glial cells: a comparison of the response of cultured astrocytes, oligodendrocytes and Schwann cells, Devel. Brain Res. 2: 19.Google Scholar
  33. Raff M.C., Abney E.R. and Fok-Seang J. 1985. Reconstitution of a developmental clock in vitro: a critical role for astrocytes in the timing of oligodendrocyte differentiation, Cell 42: 61.PubMedCrossRefGoogle Scholar
  34. Raff M.C., Lilien L.E., Richardson W.D., Burne J.F. and Noble M. 1988. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture, Nature 333: 562.PubMedCrossRefGoogle Scholar
  35. Raff M.C., Miller R.H. and Noble M. 1983. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on the culture medium. Nature 274: 813.Google Scholar
  36. Reul J. and De Kloet E.R. 1985. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation, Endocrinology 117: 2505.PubMedCrossRefGoogle Scholar
  37. Richardson W.D., Pringle N., Mosleuy M.J., Westermark R. and Dubois-Dalcq M. 1988. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system, Cell 53: 310.CrossRefGoogle Scholar
  38. Richardson W.D., Raff M. and Noble M. 1990. The oligodendrocyte-type-2 astrocyte lineage, Semin. Neurosci. 2: 451.Google Scholar
  39. Ross M.E. 1996. Cell division and the nervous system: regulating the cycle from neural differentiation to death. Trends Neurosci. 19: 62–68.PubMedCrossRefGoogle Scholar
  40. Sakellaridis N., Mangoura D. and Vernadakis A. 1984. Glial cell growth in culture: influence of living cell substrata, Neurochem. Res. 9: 1477.Google Scholar
  41. Sanchez I., Goya L., Vallerga A.K. and Firestone G.L. 1993. Glucocorticoids reversibly arrest rat hepatoma cell growth by inducing an early GI block in cell cycle progression, Cell Growth Differ. 4: 215.PubMedGoogle Scholar
  42. Sherr C.J. 1993. Mammalian GI cyclins, Cell 73: 1059.PubMedCrossRefGoogle Scholar
  43. Simon M.I., Strathmann M.P. and Gautam N. 1991. Diversity of G proteins in signal transduction, Science 252: 802.PubMedCrossRefGoogle Scholar
  44. Simpson D.L., Morrison R., De Vellis J. and Herschman J.R. 1982. Epidermal growth factor binding and mitogen activity on purified populations of cells from the central nervous system, J. Neurosci. Res. 8: 453.Google Scholar
  45. Thomas G. 1992. MAP kinase by any other name smells just as sweet, Cell 68: 3.PubMedCrossRefGoogle Scholar
  46. Truss M. and Beato M. 1993. Steroid hormone receptors: interaction with deoxyribonucleoic acid and transcription factors, Endocr. Rev. 14: 459.Google Scholar
  47. Ullrich A. and Schlessinger J. 1990. Signal transduction by receptors with tyrosine kinase activity, Cell 61: 203.PubMedCrossRefGoogle Scholar
  48. Vernadakis A., Lee K., Kentroti S. and Brodie C. 1992. Role of astrocytes in aging: late passage primary mouse brain astrocytes and C6 glial cells as models, Prog. Brain Res. 94: 391.Google Scholar
  49. Vielkind U., Walencewicz A., Levine J.M. and Churchill-Bohn M. 1990. Type Il glucocorticoid receptors are expressed in olygodendrocytes and astrocytes, J. Neurosci. Res. 27: 360.Google Scholar
  50. Williams L.T. 1989. Signal transduction by the platelet-derived growth factor receptor, Science 243: 1564.PubMedCrossRefGoogle Scholar
  51. Zipori D. 1992. The renewal and differentiation of hematopoietic stem cells, FASEB J. 6: 2691.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Luis Goya
    • 1
  1. 1.Research Associate at the Instituto de Bioquímica (CSIC-UCM)Facultad de Farmacia, Ciudad UniversitariaMadridSpain

Personalised recommendations